About the Annual General Meeting 2003
Santen Pharmaceutical Co., Ltd. held its 91st Annual General Meeting of
Shareholders on June 26, 2003. The Meeting started at 10:00 a.m. and ended
at 11:07 a.m. The number of shareholders attended was 118.
Matters reported:
Santen reported the non-consolidated balance sheets as of March 31, 2003,
and the non-consolidated statements of income and operational review for
the 91st business term (April 1, 2002 to March 31, 2003).
Matters resolved:
Eight items of business as described below were resolved.
Resolution [PDF:13KB]
Questions:
Three shareholders submitted the following questions and the
Board of Directors answered each question.
- Sales strategy for OTC eye drops
- Details of the loss from liquidation of a subsidiary
- Outlook for overseas business
- Factor for decreased earnings per share and countermeasures
Back to top
|
|
|
